The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

PIM1 is over-expressed in multiple tumors, including prostate cancer (PCa). PIM1 upregulation is mediated by direct binding of the ERG transcription factor to its promoter. About 50% of PCa cases are characterized by the presence of the TMPRSS2/ERG fusion, leading to ERG over-expression and thus to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mologni, Luca, Magistroni, Vera, Casuscelli, Francesco, Montemartini, Marisa, Gambacorti-Passerini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Short Research Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264050/
https://www.ncbi.nlm.nih.gov/pubmed/28123608
http://dx.doi.org/10.7150/jca.15838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264050/
https://www.ncbi.nlm.nih.gov/pubmed/28123608
http://dx.doi.org/10.7150/jca.15838

Ejemplares similares